4 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Daliresp (Roflumilast ... Dosing: 250 mcg tablet ... recommendations for the treatment ... won’t have any clinical ... #Indications #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... #Management #Pulmonary ... #COPD #GOLD2017 ... #Guidelines
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #differential #algorithm ... #treatment #table ... #heartfailure #chf ... #clinical #pharmacology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... May have typical HF ... Delivery • Stable ... e.g., <50%), ESC guidelines ... #cardiology #treatment